John Frater

Medicine & Life Sciences

1. Lymphoma 100%
2. Hematology 95%
3. B-Cell Chronic Lymphocytic Leukemia 83%
4. Acute Myeloid Leukemia 80%
5. Skin 73%
6. Bone Marrow 68%
7. Leukemia 64%
8. Mantle-Cell Lymphoma 63%
9. Myeloid Sarcoma 62%
10. B-Lymphocytes 59%
11. Cytogenetics 53%
12. Flow Cytometry 48%
13. Pandemics 45%
14. Neoplasms 44%
15. T-Cell Prolymphocytic Leukemia 43%
16. Hodgkin Disease 43%
17. Sinus Histiocytosis 41%
18. Tertiary Care Centers 39%
19. Myelodysplastic Syndromes 39%
20. Differential Diagnosis 38%
21. Biopsy 38%
22. T-Lymphocytes 37%
23. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 37%
24. Molecular Pathology 35%
25. Lymphoproliferative Disorders 34%
26. Differentiation Antigens 34%
27. Fluorescence In Situ Hybridization 34%
28. Lymphoma, Large B-Cell, Diffuse 33%
29. Malformations of Cortical Development 32%
30. Drug Resistant Epilepsy 32%
31. Cell Lineage 30%
32. Lymphocytosis 28%
33. Non-Hodgkin's Lymphoma 28%
34. Lymph Nodes 28%
35. Chromosomes 27%
36. Central Nervous System 27%
37. Genes 27%
38. Immunohistochemistry 27%
39. Interphase 27%
40. Trisomy 3q Chromosome 3 26%
41. Plasma Cells 26%
42. Hematologic Neoplasms 26%
43. Molecular Biology 26%
44. Reed-Sternberg Cells 25%
45. Histiocytic Sarcoma 25%
46. Cerebrospinal Fluid 24%
47. Histiocytosis 23%
48. Mast-Cell Leukemia 23%
49. midostaurin 23%
50. Eosinophilia 23%